IDH2 and glioblastoma: In contrast, the ones leading to secondary GBM are tumor protein 53 (TP53) (chromosome 17), isocitrate dehydrogenase 1 (IDH1), and isocitrate dehydrogenase 2 (IDH2) mutations [7].